ONCOPEP INC has a total of 12 patent applications. It increased the IP activity by 40.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and biotechnology are ALLYSTA PHARMACEUTICALS INC, AMAL THERAPEUTICS SA and REMEGEN LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United States | 2 | |
#5 | Australia | 1 | |
#6 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Peterkin Doris | 12 |
#2 | Cohen Marc A | 9 |
#3 | Cohen Marc | 3 |
Publication | Filing date | Title |
---|---|---|
WO2019083960A1 | Peptide vaccines and hdac inhibitors for treating multiple myeloma | |
WO2019083962A1 | Peptide vaccines and pembrolizumab for treating breast cancer | |
WO2018039203A1 | Peptide vaccines and durvalumab for treating multiple myeloma | |
WO2018039205A1 | Peptide vaccines and durvalumab for treating breast cancer |